Which has higher earnings and valuation, LNTH or PEN?

Lantheus has higher revenue and earnings than Penumbra. Lantheus is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lantheus $1.54B 4.24 $233.56M $4.14 24.19 Penumbra $1.40B 8.96 $177.69M $4.07 78.45

Is LNTH or PEN more profitable?

Lantheus has a net margin of 17.69% compared to Penumbra's net margin of 10.67%. Lantheus' return on equity of 28.10% beat Penumbra's return on equity. Company Net Margins Return on Equity Return on Assets Lantheus 17.69% 28.10% 14.35% Penumbra 10.67% 10.50% 8.17%

Does the media prefer LNTH or PEN?

In the previous week, Penumbra had 3 more articles in the media than Lantheus. MarketBeat recorded 7 mentions for Penumbra and 4 mentions for Lantheus. Lantheus' average media sentiment score of 0.79 beat Penumbra's score of 0.43 indicating that Lantheus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lantheus 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, ITGR or PEN?

Penumbra has lower revenue, but higher earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.84B 2.34 $102.81M $3.66 34.60 Penumbra $1.40B 8.96 $177.69M $4.07 78.45

Is ITGR or PEN more profitable?

Penumbra has a net margin of 10.67% compared to Integer's net margin of 6.97%. Integer's return on equity of 12.79% beat Penumbra's return on equity. Company Net Margins Return on Equity Return on Assets Integer 6.97% 12.79% 6.48% Penumbra 10.67% 10.50% 8.17%

Does the media prefer ITGR or PEN?

In the previous week, Penumbra had 3 more articles in the media than Integer. MarketBeat recorded 7 mentions for Penumbra and 4 mentions for Integer. Penumbra's average media sentiment score of 0.43 beat Integer's score of 0.28 indicating that Penumbra is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Penumbra 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor EW or PEN?

In the previous week, Edwards Lifesciences had 7 more articles in the media than Penumbra. MarketBeat recorded 14 mentions for Edwards Lifesciences and 7 mentions for Penumbra. Edwards Lifesciences' average media sentiment score of 0.44 beat Penumbra's score of 0.43 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 4 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Penumbra 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor BDX or PEN?

In the previous week, Becton, Dickinson and Company had 22 more articles in the media than Penumbra. MarketBeat recorded 29 mentions for Becton, Dickinson and Company and 7 mentions for Penumbra. Becton, Dickinson and Company's average media sentiment score of 0.50 beat Penumbra's score of 0.43 indicating that Becton, Dickinson and Company is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Becton, Dickinson and Company 8 Very Positive mention(s) 5 Positive mention(s) 15 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to PEN or IDXX?

In the previous week, Penumbra had 1 more articles in the media than IDEXX Laboratories. MarketBeat recorded 7 mentions for Penumbra and 6 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.53 beat Penumbra's score of 0.43 indicating that IDEXX Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IDEXX Laboratories 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Penumbra (PEN) Competitors

$320.80 +1.40 (+0.44%)

Closing price 03:59 PM Eastern

Extended Trading

$320.96 +0.16 (+0.05%)

As of 04:56 PM Eastern

Compare

PEN vs. LNTH, ITGR, EW, BDX, and IDXX

Should you buy Penumbra stock or one of its competitors? Penumbra's main competitors and comparable companies include Lantheus (LNTH), Integer (ITGR), Edwards Lifesciences (EW), Becton, Dickinson and Company (BDX), and IDEXX Laboratories (IDXX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Penumbra compare to Lantheus?

Lantheus (NASDAQ:LNTH) and Penumbra (NYSE:PEN) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

99.1% of Lantheus shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 1.7% of Lantheus shares are owned by insiders. Comparatively, 2.9% of Penumbra shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Lantheus presently has a consensus target price of $108.11, indicating a potential upside of 7.95%. Penumbra has a consensus target price of $367.07, indicating a potential upside of 14.97%. Given Penumbra's higher possible upside, analysts plainly believe Penumbra is more favorable than Lantheus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lantheus	0 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.29
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

Lantheus has a net margin of 17.69% compared to Penumbra's net margin of 10.67%. Lantheus' return on equity of 28.10% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lantheus	17.69%	28.10%	14.35%
Penumbra	10.67%	10.50%	8.17%

In the previous week, Penumbra had 3 more articles in the media than Lantheus. MarketBeat recorded 7 mentions for Penumbra and 4 mentions for Lantheus. Lantheus' average media sentiment score of 0.79 beat Penumbra's score of 0.43 indicating that Lantheus is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lantheus	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Lantheus has a beta of -0.06, meaning that its share price is 106% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market.

Lantheus has higher revenue and earnings than Penumbra. Lantheus is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lantheus	$1.54B	4.24	$233.56M	$4.14	24.19
Penumbra	$1.40B	8.96	$177.69M	$4.07	78.45

Summary

Lantheus beats Penumbra on 10 of the 16 factors compared between the two stocks.

How does Penumbra compare to Integer?

Integer (NYSE:ITGR) and Penumbra (NYSE:PEN) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation, profitability and media sentiment.

Penumbra has a net margin of 10.67% compared to Integer's net margin of 6.97%. Integer's return on equity of 12.79% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Penumbra	10.67%	10.50%	8.17%

In the previous week, Penumbra had 3 more articles in the media than Integer. MarketBeat recorded 7 mentions for Penumbra and 4 mentions for Integer. Penumbra's average media sentiment score of 0.43 beat Integer's score of 0.28 indicating that Penumbra is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Penumbra	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Penumbra has lower revenue, but higher earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.84B	2.34	$102.81M	$3.66	34.60
Penumbra	$1.40B	8.96	$177.69M	$4.07	78.45

Integer currently has a consensus price target of $109.86, indicating a potential downside of 13.25%. Penumbra has a consensus price target of $367.07, indicating a potential upside of 14.97%. Given Penumbra's stronger consensus rating and higher possible upside, analysts clearly believe Penumbra is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

Integer has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, meaning that its share price is 30% less volatile than the broader market.

99.3% of Integer shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 1.1% of Integer shares are owned by insiders. Comparatively, 2.9% of Penumbra shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Penumbra beats Integer on 13 of the 16 factors compared between the two stocks.

How does Penumbra compare to Edwards Lifesciences?

Edwards Lifesciences (NYSE:EW) and Penumbra (NYSE:PEN) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Edwards Lifesciences has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market.

79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by company insiders. Comparatively, 2.9% of Penumbra shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Edwards Lifesciences has higher revenue and earnings than Penumbra. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edwards Lifesciences	$6.51B	7.54	$1.07B	$1.74	49.00
Penumbra	$1.40B	8.96	$177.69M	$4.07	78.45

Edwards Lifesciences presently has a consensus target price of $100.27, suggesting a potential upside of 17.60%. Penumbra has a consensus target price of $367.07, suggesting a potential upside of 14.97%. Given Edwards Lifesciences' stronger consensus rating and higher probable upside, research analysts plainly believe Edwards Lifesciences is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edwards Lifesciences	0 Sell rating(s)	5 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.82
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

Edwards Lifesciences has a net margin of 15.43% compared to Penumbra's net margin of 10.67%. Edwards Lifesciences' return on equity of 15.68% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edwards Lifesciences	15.43%	15.68%	12.05%
Penumbra	10.67%	10.50%	8.17%

In the previous week, Edwards Lifesciences had 7 more articles in the media than Penumbra. MarketBeat recorded 14 mentions for Edwards Lifesciences and 7 mentions for Penumbra. Edwards Lifesciences' average media sentiment score of 0.44 beat Penumbra's score of 0.43 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edwards Lifesciences	4 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Penumbra	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Edwards Lifesciences beats Penumbra on 12 of the 17 factors compared between the two stocks.

How does Penumbra compare to Becton, Dickinson and Company?

Becton, Dickinson and Company (NYSE:BDX) and Penumbra (NYSE:PEN) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment and valuation.

Becton, Dickinson and Company has a beta of 0.21, meaning that its stock price is 79% less volatile than the broader market. Comparatively, Penumbra has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market.

Becton, Dickinson and Company has higher revenue and earnings than Penumbra. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and Company	$21.84B	2.32	$1.68B	$3.32	55.33
Penumbra	$1.40B	8.96	$177.69M	$4.07	78.45

In the previous week, Becton, Dickinson and Company had 22 more articles in the media than Penumbra. MarketBeat recorded 29 mentions for Becton, Dickinson and Company and 7 mentions for Penumbra. Becton, Dickinson and Company's average media sentiment score of 0.50 beat Penumbra's score of 0.43 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and Company	8 Very Positive mention(s)	5 Positive mention(s)	15 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Penumbra has a net margin of 10.67% compared to Becton, Dickinson and Company's net margin of 4.52%. Becton, Dickinson and Company's return on equity of 14.79% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and Company	4.52%	14.79%	6.93%
Penumbra	10.67%	10.50%	8.17%

Becton, Dickinson and Company presently has a consensus price target of $185.07, suggesting a potential upside of 0.75%. Penumbra has a consensus price target of $367.07, suggesting a potential upside of 14.97%. Given Penumbra's higher possible upside, analysts plainly believe Penumbra is more favorable than Becton, Dickinson and Company.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and Company	1 Sell rating(s)	9 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.35
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 88.9% of Penumbra shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by insiders. Comparatively, 2.9% of Penumbra shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Penumbra beats Becton, Dickinson and Company on 9 of the 16 factors compared between the two stocks.

How does Penumbra compare to IDEXX Laboratories?

Penumbra (NYSE:PEN) and IDEXX Laboratories (NASDAQ:IDXX) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, dividends and earnings.

In the previous week, Penumbra had 1 more articles in the media than IDEXX Laboratories. MarketBeat recorded 7 mentions for Penumbra and 6 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.53 beat Penumbra's score of 0.43 indicating that IDEXX Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
IDEXX Laboratories	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

IDEXX Laboratories has a net margin of 25.03% compared to Penumbra's net margin of 10.67%. IDEXX Laboratories' return on equity of 71.96% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	10.67%	10.50%	8.17%
IDEXX Laboratories	25.03%	71.96%	33.60%

Penumbra has a beta of 0.7, meaning that its stock price is 30% less volatile than the broader market. Comparatively, IDEXX Laboratories has a beta of 1.55, meaning that its stock price is 55% more volatile than the broader market.

Penumbra currently has a consensus target price of $367.07, suggesting a potential upside of 14.97%. IDEXX Laboratories has a consensus target price of $747.00, suggesting a potential upside of 44.21%. Given IDEXX Laboratories' stronger consensus rating and higher possible upside, analysts plainly believe IDEXX Laboratories is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60

88.9% of Penumbra shares are held by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are held by institutional investors. 2.9% of Penumbra shares are held by insiders. Comparatively, 0.8% of IDEXX Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

IDEXX Laboratories has higher revenue and earnings than Penumbra. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.40B	8.96	$177.69M	$4.07	78.45
IDEXX Laboratories	$4.30B	9.48	$1.06B	$14.22	36.43

Summary

IDEXX Laboratories beats Penumbra on 12 of the 16 factors compared between the two stocks.

Get Penumbra News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PEN vs. The Competition

Export

Metric	Penumbra	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$12.64B	$5.56B	$7.26B	$23.08B
Dividend Yield	N/A	1.77%	2.53%	3.72%
P/E Ratio	78.82	25.89	275.65	28.54
Price / Sales	9.00	70.20	599.73	17.86
Price / Cash	74.30	32.56	27.30	19.30
Price / Book	8.80	6.01	10.85	4.71
Net Income	$177.69M	$146.14M	$3.50B	$1.07B
7 Day Performance	1.07%	-0.64%	-2.14%	-0.18%
1 Month Performance	0.92%	-2.17%	-4.88%	-3.59%
1 Year Performance	22.93%	4.31%	6.00%	9.32%

Penumbra Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PEN Penumbra	2.3212 of 5 stars	$320.80 +0.4%	$367.07 +14.4%	+22.3%	$12.64B	$1.40B	78.82	4,700
LNTH Lantheus	3.7889 of 5 stars	$100.19 +0.2%	$108.11 +7.9%	+87.1%	$6.52B	$1.54B	24.20	1,193
ITGR Integer	1.9268 of 5 stars	$126.62 +0.1%	$109.86 -13.2%	+25.4%	$4.30B	$1.85B	34.60	11,000
EW Edwards Lifesciences	3.8978 of 5 stars	$87.29 +2.5%	$100.27 +14.9%	+15.2%	$49.03B	$6.51B	50.16	16,000	Positive News
BDX Becton, Dickinson and Company	3.2788 of 5 stars	$180.57 +2.1%	$187.67 +3.9%	-1.5%	$48.72B	$21.84B	54.39	72,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PEN) was last updated on 10/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Penumbra (PEN) Competitors

PEN vs. LNTH, ITGR, EW, BDX, and IDXX

How does Penumbra compare to Lantheus?

Summary

How does Penumbra compare to Integer?

Summary

How does Penumbra compare to Edwards Lifesciences?

Summary

How does Penumbra compare to Becton, Dickinson and Company?

Summary

How does Penumbra compare to IDEXX Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PEN vs. The Competition

Penumbra Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Penumbra (PEN) Competitors

PEN vs. LNTH, ITGR, EW, BDX, and IDXX

How does Penumbra compare to Lantheus?

Do insiders & institutionals have more ownership in LNTH or PEN?

Do analysts prefer LNTH or PEN?

Is LNTH or PEN more profitable?

Does the media prefer LNTH or PEN?

Which has more volatility and risk, LNTH or PEN?

Which has higher earnings and valuation, LNTH or PEN?

Summary

How does Penumbra compare to Integer?

Is ITGR or PEN more profitable?

Does the media prefer ITGR or PEN?

Which has preferable valuation and earnings, ITGR or PEN?

Do analysts prefer ITGR or PEN?

Which has more risk & volatility, ITGR or PEN?

Do institutionals and insiders have more ownership in ITGR or PEN?

Summary

How does Penumbra compare to Edwards Lifesciences?

Which has more volatility & risk, EW or PEN?

Do institutionals & insiders have more ownership in EW or PEN?

Which has stronger earnings & valuation, EW or PEN?

Do analysts prefer EW or PEN?

Is EW or PEN more profitable?

Does the media favor EW or PEN?

Summary

How does Penumbra compare to Becton, Dickinson and Company?

Which has more volatility and risk, BDX or PEN?

Which has better valuation & earnings, BDX or PEN?

Does the media favor BDX or PEN?

Is BDX or PEN more profitable?

Do analysts prefer BDX or PEN?

Do institutionals and insiders have more ownership in BDX or PEN?

Summary

How does Penumbra compare to IDEXX Laboratories?

Does the media refer more to PEN or IDXX?

Is PEN or IDXX more profitable?

Which has more risk and volatility, PEN or IDXX?

Do analysts recommend PEN or IDXX?

Do insiders and institutionals have more ownership in PEN or IDXX?

Which has preferable valuation & earnings, PEN or IDXX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PEN vs. The Competition

Penumbra Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools